Loading clinical trials...
Loading clinical trials...
The purpose of this study is to compare different estimates of calculating creatinine clearance by mathematical formula and compare them to creatinine clearance based on a timed urine collection in pa...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dana-Farber Cancer Institute
NCT06931652 · Primary CNS Lymphoma (PCNSL)
NCT05098613 · Non-Hodgkin Lymphoma, B-cell Non-Hodgkin Lymphoma (B-NHL), and more
NCT05036564 · Primary CNS Lymphoma
NCT05351593 · CNS Lymphoma, Primary Central Nervous System Lymphoma, and more
NCT05926427 · CNS Lymphoma
Dana-Farber Cancer Institute
Boston, Massachusetts
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions